CCL2 and obesity disorder: A pro-inflammatory role for glucocorticoid-activated MR is suggested; eplerenone treatment of ob/ob mice prevented the obesity-associated increases in MCP-1, TNF-α and other inflammatory markers in adipose tissue [136].